ArticleFrontiers in microbiology2026
Antimicrobial resistance in uropathogens in Nigeria: pathogen profiles, resistance burden, surveillance and stewardship considerations.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We analyzed aggregated national surveillance data to describe uropathogen resistance patterns and assess limitations in the available laboratory and surveillance information from Nigeria. Methods: In a secondary data study, we retrospectively analyzed a total of 84,548 valid culture results from 26,630 patients across 25 public laboratories who participated in the national AMR report. The World Health Organization (WHO) bacterial priority uropathogens and their AMR profiles for the key urinary tract infections (UTIs) antibiotic classes were assessed. Results: More than 6,000 urine specimens were submitted for culture. The source report included both genus-level and species-level bacterial identifications. Conclusion: High reported resistance to several antimicrobial classes was observed among bacterial taxa included in the surveillance report. Our findings provide a historical descriptive summary and suggest priorities for future surveillance; to address existing national antimicrobial resistance patterns and demonstrating the effectiveness of specific clinical or policy interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.